Evidence map›Paper›PMID 40200944›Full record

ArticleJournal of biological methods2025

Integration of an automated cell culture analyzer with a closed-system hollow-fiber bioreactor for online metabolite detection and cell monitoring.

Nathan Schwab, Nathan Frank, Tonya Acker, Kelly Richardson, Mindy Miller

Abstract read
In one paragraph

Article in Journal of biological methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nathan SchwabDepartment of Research and Development, Terumo Blood and Cell Technologies, Lakewood, Colorado 80215, United States.
Nathan FrankDepartment of Research and Development, Terumo Blood and Cell Technologies, Lakewood, Colorado 80215, United States.
Tonya AckerDepartment of Research and Development, Terumo Blood and Cell Technologies, Lakewood, Colorado 80215, United States.
Kelly RichardsonDepartment of Nova BioProfile Applications, Nova Biomedical, Waltham, Massachusetts 02454, United States.
Mindy MillerDepartment of Research and Development, Terumo Blood and Cell Technologies, Lakewood, Colorado 80215, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: On-line sensing technologies for expanding cell cultures are becoming essential tools for understanding metabolic activity during critical stages of expansion. These tools generate data that indicate when user interventions are required, such as harvesting cells or cell products, inducing cell differentiation, or altering growth medium inputs. The platform must reliably measure the biochemical and physiochemical properties of interest in a dependable, aseptic, and non-invasive manner to benefit users. Objective: In this proof-of-concept study, we used the Nova Biomedical BioProfile FLEX2 as a platform for metabolic and cellular measurements due to its ability to detect a range of metabolically relevant compounds, measure cell counts and viability, and acquire samples automatically. Methods: Here, we demonstrated the straightforward integration of the analyzer with the Quantum Flex™ Cell Expansion System (Quantum Flex) using an available sampling port. While this approach can accommodate both suspension and adherent cell types, this study focused on suspension cells only. In addition, we developed a simple method to integrate the sampling adapter into a Quantum cell expansion set, allowing sample collection at precise intervals. Results: In both cases, the samples were acquired automatically using the analyzer's timing function, facilitating an automated expansion process with increased data collection frequency - previously impractical with manual sampling. Conclusion: This model provides Quantum Flex users with an option for online sensing to monitor cell expansion at scheduled intervals without requiring additional user input.

Indexed as

Hollow-fiber bioreactorMetabolic monitoringNova Biomedical BioProfile FLEX2On-line sensingQuantum Flex

Identifiers

PMID40200944
PMCPMC11973053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.